THIRD SUPPLEMENTAL INDENTURESupplemental Indenture • September 12th, 2011 • Pathology Solutions, LLC • New York
Contract Type FiledSeptember 12th, 2011 Company JurisdictionThird Supplemental Indenture (this “Supplemental Indenture”), dated as of June 2, 2011, among Derm Path New England, LLC, a Massachusetts limited liability company (the “Additional Subsidiary Guarantor”), Aurora Diagnostics Holdings, LLC, a Delaware limited liability company (the “Company”), Aurora Diagnostics Financing, Inc., a Delaware corporation (the “Co-Issuer” and, together with the Company, the “Issuers”), and U.S. Bank National Association (the “Trustee”).
FIRST SUPPLEMENTAL INDENTURESupplemental Indenture • September 12th, 2011 • Pathology Solutions, LLC • New York
Contract Type FiledSeptember 12th, 2011 Company JurisdictionFirst Supplemental Indenture (this “Supplemental Indenture”), dated as of December 31, 2010, among Texas Pathology, LLC, a Texas limited liability company (the “Additional Subsidiary Guarantor”), Aurora Diagnostics Holdings, LLC, a Delaware limited liability company (the “Company”), Aurora Diagnostics Financing, Inc., a Delaware corporation (the “Co-Issuer” and, together with the Company, the “Issuers”), and U.S. Bank National Association (the “Trustee”).